A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma

BACKGROUND: The prognosis of patients with peripheral T-cell (PTCL) or lymphoblastic T-cell lymphoma (T-LBL) remains poor under current conditioning regimens before receiving autologous stem cell transplantation (ASCT). METHODS: Patients with PTCL or T-LBL were enrolled to receive ASCT using the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qiang, Zhang, Hang, Kuang, Pu, Li, Jian, Chen, Xinchuan, Dong, Tian, Wu, Qiuhui, Zhang, Chuanli, Chen, Chunping, Niu, Ting, Liu, Ting, Liu, Zhigang, Ji, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034030/
https://www.ncbi.nlm.nih.gov/pubmed/36969020
http://dx.doi.org/10.3389/fonc.2023.1143556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034030/
https://www.ncbi.nlm.nih.gov/pubmed/36969020
http://dx.doi.org/10.3389/fonc.2023.1143556

Ejemplares similares